Loading...
XIDX
HEAL
Market cap1.24bUSD
May 19, Last price  
1,375.00IDR
1D
1.85%
1Q
-0.72%
IPO
111.54%
Name

Medikaloka Hermina Tbk PT

Chart & Performance

D1W1MN
XIDX:HEAL chart
P/E
37.94
P/S
3.02
EPS
36.25
Div Yield, %
0.62%
Shrs. gr., 5y
-0.23%
Rev. gr., 5y
13.16%
Revenues
6.74t
+16.47%
1,709,020,000,0002,234,263,000,0002,678,197,000,0003,058,091,000,0003,630,940,000,0004,416,042,000,0005,820,123,000,0004,901,810,000,0005,784,086,000,0006,736,730,000,000
Net income
535.94b
+22.54%
19,298,000,00061,996,000,00097,549,000,000124,374,000,000343,920,000,000645,638,000,000995,974,000,000298,596,000,000437,346,000,000535,942,000,000
CFO
0k
-100.00%
255,710,000,000362,845,000,000465,081,000,000241,671,000,000572,580,000,0001,126,485,000,0001,856,336,000,000503,582,000,0001,319,655,000,0000
Dividend
May 22, 20248.5 IDR/sh

Profile

PT Medikaloka Hermina Tbk operates a network of general hospitals in Indonesia. As of December 31, 2021, the company operated 43 hospitals with 5,877 beds. It is also involved in the investment and education service businesses. The company was founded in 1985 and is based in Jakarta, Indonesia.
URL
https://www.herminahospitals.com/
IPO date
May 16, 2018
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
6,736,730,000
16.47%
5,784,086,000
18.00%
4,901,810,000
-15.78%
Cost of revenue
4,464,495,000
4,115,951,000
3,422,456,000
Unusual Expense (Income)
NOPBT
2,272,235,000
1,668,135,000
1,479,354,000
NOPBT Margin
33.73%
28.84%
30.18%
Operating Taxes
218,020,000
151,109,000
101,315,000
Tax Rate
9.59%
9.06%
6.85%
NOPAT
2,054,215,000
1,517,026,000
1,378,039,000
Net income
535,942,000
22.54%
437,346,000
46.47%
298,596,000
-70.02%
Dividends
(126,565,000)
(101,442,000)
(86,664,000)
Dividend yield
0.52%
0.46%
0.39%
Proceeds from repurchase of equity
167,650,000
49,015,000
(95,949,000)
BB yield
-0.69%
-0.22%
0.43%
Debt
Debt current
408,981,000
258,195,000
574,974,000
Long-term debt
2,844,894,000
2,007,529,000
1,165,878,000
Deferred revenue
649,000
23,000
448,000
Other long-term liabilities
61,144,000
48,771,000
33,147,000
Net debt
2,610,639,000
1,410,081,000
965,464,000
Cash flow
Cash from operating activities
1,319,655,000
503,582,000
CAPEX
(2,281,991,000)
(1,591,362,000)
(1,129,010,000)
Cash from investing activities
(2,363,470,000)
(1,677,866,000)
(1,220,705,000)
Cash from financing activities
1,013,803,000
438,476,000
(158,604,000)
FCF
266,822,000
490,303,000
760,149,000
Balance
Cash
643,236,000
855,643,000
775,388,000
Long term investments
Excess cash
306,399,500
566,438,700
530,297,500
Stockholders' equity
4,548,247,000
3,622,615,000
3,634,746,000
Invested Capital
8,860,368,500
6,941,578,300
5,773,896,500
ROIC
26.00%
23.86%
26.05%
ROCE
24.79%
22.22%
23.47%
EV
Common stock shares outstanding
14,916,213
14,713,049
14,514,451
Price
1,630.00
9.40%
1,490.00
-3.87%
1,550.00
44.86%
Market cap
24,313,427,082
10.91%
21,922,442,778
-2.56%
22,497,398,588
41.02%
EV
28,338,308,082
24,661,731,778
25,127,534,588
EBITDA
2,272,235,000
2,402,605,000
1,604,163,000
EV/EBITDA
12.47
10.26
15.66
Interest
179,099,000
139,560,000
139,833,000
Interest/NOPBT
7.88%
8.37%
9.45%